There are at least 100 experimental vaccines being studied for the novel coronavirus disease 2019 (COVID-19).
We are halfway through the year 2020 and finally some good news are being brought up.
Moderna Inc. and the National Institutes of Health
A vaccine developed by Moderna Inc. and the National Institutes of Health (NIH) will be tested in 30,000 people in the US. Their final test involves real shots and dummy shots and then carefully comparing which group winds up with the most infections.
Sinovac Biotech turned to São Paulo Brazil for at least part of its final testing, with it being the epicenter of Latin America’s outbreak. Sinovac will starts its experimental vaccine tests to 9,000 Brazilians starting next month.
There’s still a lot of COVID-19 potential vaccines that are in their early stages of testing. The NIH expects to help several additional shots move into those final, large-scale studies this summer.
Another one of great potential is the one made by Oxford University that’s also being tested in a few thousand volunteers in Brazil.
These experimental shots are from the word itself “experimental” — there is no guarantee but we can only pray and hope for the best.
Best outcome, “there will be potential to get answers” on which vaccines work by the end of the year, says Dr. John Mascola, who directs NIH’s vaccine research center.